Bavarian Nordic Aktie

31,10 EUR -0,16 EUR -0,51 %

17:30:46

FSE

31,41 EUR -0,43 EUR -1,35 %

17:50:06

GVIE

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.2,48 Mrd. EUR

KGV14,97Div. Rendite0,00%

WKN917165

ISINDK0015998017

SymbolBVNKF

Bavarian Nordic Aktien News

Sortieren:Datum Meistgelesen

17.09.24BenzingaUK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat

13.09.24GlobeNewswireBavarian Nordic Receives WHO Prequalification for Mpox Vaccine

12.09.24GlobeNewswireBavarian Nordic Provides Update on the Mpox Vaccine Supply Situation

06.09.24GlobeNewswireReport of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

05.09.24GlobeNewswireReport of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

05.09.24GlobeNewswireFirst Doses of Bavarian Nordic’s Mpox Vaccine Now Arriving in the Democratic Republic of Congo

05.09.24GlobeNewswireCapital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

27.08.24GlobeNewswireBavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Singapore

23.08.24GlobeNewswireReport of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

22.08.24GlobeNewswireBavarian Nordic Announces First Half 2024 Results

21.08.24GlobeNewswireBavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country

17.08.24GlobeNewswireBavarian Nordic Provides Statement on Mpox Vaccine Supply and Collaboration with African and Global Stakeholders

16.08.24BenzingaMpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency

16.08.24GlobeNewswireBavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to Adolescents

15.08.24BenzingaEmergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?

13.08.24GlobeNewswireBavarian Nordic Receives Order from HERA and Announces Significant Donation of Vaccines in Response to the Mpox Outbreak in Africa

13.08.24GlobeNewswireBavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine

08.08.24GlobeNewswireBavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vaccine Production

26.07.24GlobeNewswireBavarian Nordic Receives Positive CHMP Opinion for Including Mpox Real-world Effectiveness Data in European Marketing Authorization for Smallpox and Mpox Vaccine

18.07.24GlobeNewswireBavarian Nordic Receives EMA Filing Acceptance and Validation of the MAA for its Chikungunya Vaccine

01.07.24GlobeNewswireBavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan

28.06.24GlobeNewswireBavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa

26.06.24GlobeNewswireBavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to EMA

17.06.24GlobeNewswireBavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate

31.05.24GlobeNewswireBavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine

30.05.24GlobeNewswireBavarian Nordic and CEPI Partners to Advance Mpox Vaccination in Africa

22.05.24GlobeNewswireCapital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

21.05.24GlobeNewswireBavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program

21.05.24GlobeNewswireEVP and Chief Medical Officer Laurence de Moerlooze Will Be Leaving Bavarian Nordic

08.05.24GlobeNewswireBavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations

08.05.24GlobeNewswireBavarian Nordic Announces Interim Results for the First Three Months of 2024

07.05.24GlobeNewswireReport of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

29.04.24GlobeNewswireBavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve

29.04.24GlobeNewswireBavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate

22.04.24GlobeNewswireReport of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

16.04.24GlobeNewswireResolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S

02.04.24GlobeNewswireBavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.

21.03.24GlobeNewswireBavarian Nordic A/S – Notice Convening Annual General Meeting

13.03.24GlobeNewswireBavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland

12.03.24GlobeNewswireReport of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Bavarian Nordic News

Bavarian Nordic News: auf dieser Seite finden Sie alle Bavarian Nordic News und Nachrichten zur Bavarian Nordic Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Bavarian Nordic News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Bavarian Nordic News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.